SecBot SecBot
SECBOTREPLAY Home › Report › XENE

XENE · Three executive insiders at Xenon Pharmaceuticals (XENE) sold shares…

Xenon Pharmaceuticals Inc. · CLUSTER filed Mar 12, 2026 at 20:00 ET

At the news

BEARISHIMPACT 6/10

CLUSTER filed Mar 12, 2026 at 20:00 ET

Three executive insiders at Xenon Pharmaceuticals (XENE) sold shares worth over $550K in open-market transactions within a 2-day window, following the exercise of stock options. The sales represent a coordinated monetization of equity compensation, with the CEO accounting for over 70% of the total value sold.

  • CEO Ian Mortimer sold $403,584 worth of shares in a single open-market transaction on March 13, 2026.
  • Chief Legal Officer and Chief Medical Officer sold $74,112 and $77,867 respectively on March 13.
  • All three executives exercised stock options (totaling 37,500 shares) on March 12 at $0 cost, immediately preceding the sales.
  • Total open-market sales: $555,563 across 10,060 shares at $55.225 per share.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access